Copyright
©The Author(s) 2024.
World J Transplant. Sep 18, 2024; 14(3): 96637
Published online Sep 18, 2024. doi: 10.5500/wjt.v14.i3.96637
Published online Sep 18, 2024. doi: 10.5500/wjt.v14.i3.96637
Criteria name | Characteristics | Biomarkers |
Milan criteria | Single tumor > 5 cm or ≤ 3 tumors ≤ 3 cm, with no vascular invasion | |
UCSF criteria | Single nodule ≤ 6.5 cm or 2-3 nodules ≤ 4.5 cm and total tumor diameter ≤ 8 cm, with no vascular invasion | |
Seoul criteria | Tumor size (≤ 3, 3.1-5, 5.1-6.5, > 6.5 cm) and number (1, 2-3, 4-5, > 5) | AFP (≤ 20, 20.1-200, 200.1-1000, > 1000 ng/mL) |
Up-to-7 criteria | Sum of the largest tumour size and number of lesions < 7 | |
AFP-French model | Tumor size (≤ 3, 3-6, > 6 cm) and tumour number (1-3, ≥ 4) | log10 (AFP) simplified version: AFP level (≤ 100, 100-1000, > 1000 ng/mL) |
AFP/TTD criteria | Total tumor diameter ≤ 8 cm | AFP ≤ 400 ng/mL |
TTV/AFP model | Total tumor volume < 115 cm3, and no macrovascular invasion or extra-hepatic spread | AFP < 400 ng/mL |
Extended Toronto criteria | Any size or number of tumours, and no vascular invasion or extra-hepatic spread; No poorly differentiated grades; No symptoms related to cancer (weight loss >10 kg and/ ECOG ≥ 1 in 3 months) | |
Pre-MORAL score | Largest tumor size > 3 cm | Maximum AFP > 200 ng/mL, preoperative NLR ≥ 5 |
Metro ticket 2.0 model | Tumor number and size of the largest tumor | AFP (< 200, 200-400, 400-1000, > 1000 ng/mL) |
Metro ticket 2.0 + mRECIST criteria | Tumor number and size of the largest tumor; Radiological response to neoadjuvant therapies (mRECIST criteria) | AFP (< 200, 200-400, 400-1000, > 1000 ng/mL) |
Metro ticket 2.0 with LI-RADS criteria | Tumor number and size of the largest tumor (Tumor burden evaluated according to LI-RADS criteria) | log10 (AFP) |
RETREAT score | Tumor number and size (explant); Presence of vascular invasion | AFP level at transplant |
AFP score | Largest tumor size and number | AFP level |
TRAIN score | Response to LRT (mRECIST); NLR ratio waiting time till LT | AFP level |
MORAL score | Largest tumor size and number explant tumor pathology (differentiation grade) NLR ratio | AFP level |
- Citation: Badwei N. Challenges related to clinical decision-making in hepatocellular carcinoma recurrence post-liver transplantation: Is there a hope? World J Transplant 2024; 14(3): 96637
- URL: https://www.wjgnet.com/2220-3230/full/v14/i3/96637.htm
- DOI: https://dx.doi.org/10.5500/wjt.v14.i3.96637